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aorta. Baseline measurements of MDV were obiamed on each beagle prior to 2 hours 
occlusion of the left anterior descending arlery (LAD) and then repeated at 4 hours reper- 
fusion and also at day 4, 9, 16, 23 and 30 post. At day 30 post, the heart was removed 
following MDV measurement and scanned ex-viva at high spatial resolutmn before it was 
sliced and stained with TTC. 
vs. 3.4%. P=O.14), while it was asswated with death at one year (12.2% vs. 7.2%. odds 
ratio = 1.78, 95% Cl 1.41 to 2.26, P < O.OOOl). There was increased risk of death with 
increasing Cornell voltage, especially in women. (Figure) 
Results: MDV in the apical region of the heart Increased from a mean baseline value of 
0.4 f 0.1 ml/g to 0.9 * 0.05 ml/g immediately after reperfusion and remained above 0.6 
ml/g until day 4 post. From day 9 post MDV normalized except for a thin subendocardial 
rim in the apical region. High resolution ex-viva scan of the removed heart confirmed the 
location of the rim enhancement seen in the MDV image to be subendocardial. TTC 
staining further confirmed that the rim enhancement was infarcted tissue. MDV in normal 
myocardium at the lateral free wall of the left ventricle was 0.4 * 0.05 mlJg at all time 
points. 
Female 
Conclusion: We concluded from our preliminary results that ECG- gated contrast- 
enhanced CT scanning is a promising and simple approach for studying myocardial dam- 
age from &hernia and its resolution with time. 
9:45 a.m. 
869-6 Can Anatomic No-Reflow Be Prevented by 
Pharmacologic Treatment With Adenosine and 
Verapamil? 
Thor&n Reffelmann, Robert A. Kloner, The Heart Institute. Good Samaritan Hospital, 
University of Southern California, Los Angeles, CA 
Objectives: The aim was to Investigate the effects of intravenous adenosine and vera- 
pamil on anatomic no-reflow (ANR) in a rabbit model of coronary artery occlusion and 
reperfusion. 
Background: Verapamil and adenosine have been successfully used in treatment of 
clinical no-reflow after direct angioplasty for acute myocardial infarction. However, 
whether these agents reduce anatomic no-reflow associated with myocardial necrosis, 
as It occurs in animal models of coronary occlusion and repertusion, is unknown. 
Methods: ANR (thioflavin S at end of reperfusion), regional myocardlal blood flow 
(RMBF. radioactive mlcrospheres), and infarct size (IS, triphsnyltetrazolium) were com- 
pared in anesthetized, open-chest rabbits (&hernia-reperfusion: 30-120 minutes) receiv- 
ing intravenous adenosine at reperfusion (875 vglkg b&s, then 175 pglkglmin until the 
end of reperfusion) against controls (saline) (n=6, each), and rabbits treated with intrave- 
news verapamll at reperfusion (50 pglkg bolus, then 150 vg/kg/h) against saline (n=6. 
each). 
Results: Both regimes significantly lowered systolic and diastokc blood pressure. 
reduced specific vascular resistance in the risk area (RA)(adenosine: -38.7% and -38.7% 
at 30 and 120 min of reperfusion, verapamil: -52.5% and -54.3% at 30 and 120 min of 
reperiusion), and verapamil increased RMBF within the risk area (verapamil: 4&7%. 
saline: 33*5% of non-ischemic flow at 120 min of reperfusion). IS (adenosme: 
34.1*4.3%, saline: 39.6+6.2% of RA) and ANR (adenosine: 26.8*3.2%, saline: 
35.2*5.8% of RA) were not significantly different in the adenosine protocol, and signih- 
cantly correlated with each other (r=0.96). Similarly, verapamil did not result in significant 
effects on IS (verapamil: 42.2+5.9%. salme~ 36+6.3% of RAI. and ANR iveraoamll: 
37.6+5.5%. saline’ 34.9r5.7% of RA), which again showed a significant correlation 
h&96). ANCOVA analvsis revealed that neither treatment uncouoled ANR from IS. 
Conclusion: Despite reducing vascular resistance within the RA, both adenosine and 
verapamll at reperfus~on did not reduce ANR, suggesting that vasospasm is not a major 
contributor to anatomic perfusion defects in this experimental model. 
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872-l Does the Presence of Electrocardiographic Left 
Ventricular Hypertrophy Predict One-Year Mortality in 
Non-ST Elevation Acute Coronary Syndromes? 
Michael S. Lauer, Yuling Fu, Wei-Ching Chang, Robert M. Califf, Maarten Simoons, Lars 
Wallentin, Eric J. Topol. Paul W. Armstrong, Cleveland Clinic Foundation, Cleveland, 
OH, University of Alberta, Edmonton, Canada 
Background: Whereas electrocardiographic (ECG) left ventricular hypertrophy (LVH) 
predicts long-term mortality in otherwise healthy people, its importance as a predictor of 
death in the setting of NSTEMI acute coronary syndromes (ACS) is not known. 
Methods: Patients wth ACS who were enrolled in the GUSTO IV randomized trial had 
baseline ECGs read in a blinded core laboratory. LV mass was assessed by Cornell volt- 
age, which is the sum of the amplitude of the S wave in V3 and the R wave in lead Vl. 
LVH was defined as a voltage? 26 mm in men and 220 mm in women. 
Results: Baseline ECG data were available in 7443 (95%) of 7800 patients enrolled. 
ECG LVH was present in 747 patients (10%). During follow-up, 260 patients (3.5%) died 
by 30 days and 574 (7.7%) by 1 year. ECG LVH tended to predict death at 30 days (4.4% 
After adjusting for age, ST-segment depression, troponin, C reactive protein, and other 
confounders using logistic regression, Cornell voltage remained independently predictive 
of l-year mortality (p=O.OlE), but only in women (p&O31 for the interaction between 
Cornell voltage and sex; I” gender specific analyses, p=O.O05 and 0.339 for Cornell volt- 
age in women and men, respectively). 
Conclusion: EGG LVH at baseline is an independent predictor of lyear mortality among 
women presenting with ACS. 
8:45 a.m. 
872-2 The Prognostic Value of ST-Segment Elevation in Lead 
AVR in Patients With a First Acute Myocardial Infarction 
Without Other ST Elevation 
Jose A. BarrabBe Jaume Figueras, Cristina Moure, Josefa Cortadellas, Jordi Soler- 
Sole,, Hospital Universitari Vail d’Hebron. Barcelona, Spain 
Background: ST segment elevation (STE) in lead aVR has been associated with severe 
coronary lesions in patients with acute coronary syndromes, but the prognostic signifi- 
cance of this finding is unknown. 
Methods: We analyzed the initial EGG in 775 consecutive patients admitted to ~urcenter 
with a first acute myocardial infarction without STE in leads other than aVR. 
Results: Compared to the remaining patients, those with STE in lead aVR had a higher 
baseline risk profile and a more frequent and extensive ST segment depression in other 
leads. The rates of death and other in-hospital complications were strongly associated 
with the magmtude of STE in lead aVR, while CK-MB levels were not (Table). After 
adjustment for age, Killip class and presence and location of ST segment depression, the 
odds ratios for death in the last two groups shown in the table were, respectively, 5.6 
(95% confidence interval, 2.0-15.5) and 7.6 (3.1-19.9). Among 437 patients catheterized 
within SIX months, those wth STE in lead aVR had a lower left ventricular ejection frac- 
tion and a more extensive coronary artery disease. 
Conclusion: Lead aVR contains important prognostic information in patients with a first 
acute myocardial infarction without other STE. As the wrse wtcome predicted by STE 
in lead aVR appears to be related to a more s?vera coronary artery disease, an early 
invasive approach might be especially beneficial in these patients. 
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